Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients
Annals of Laboratory Medicine · 2024
DOI: 10.3343/alm.2024.44.1.64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2024. Verfasst von Ahram Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: COVID-19, Kidney Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University Hospital.
Abstract (Originalsprache)
Background
Whether anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody levels post-third coronavirus disease (COVID-19) vaccination correlate with worse outcomes due to breakthrough infection is unclear. We evaluated the association between anti-SARS-CoV-2 antibody levels and symptomatic breakthrough infection or hospitalization during the Omicron surge in kidney transplant recipients.
Methods
In total, 287 kidney transplant recipients expected to receive a third vaccination were enrolled between November 2021 and February 2022. The Abbott SARS-CoV-2 IgG II Quant test (Abbott, Chicago, IL, USA) was performed within three weeks before and four weeks after the third vaccination. The incidence of symptomatic breakthrough infection and hospitalization from two weeks to four months post-third vaccination was recorded.
Results
After the third vaccination, the seropositive rate and median antibody titer of the 287 patients increased from 57.1% to 82.2% and from 71.7 (interquartile range [IQR] 7.2-402.8) to 1,612.1 (IQR 153.9-5,489.1) AU/mL, respectively. Sixty-four (22.3%) patients had symptomatic breakthrough infections, of whom 12 required hospitalization. Lower anti-receptor-binding domain (RBD) IgG levels (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Transplantation Research Institute, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Ahram Han, Sangil Min, Eun-Ah Jo, Hajeong Lee, Yong Chul Kim, Seung Seok Han, Hee Gyung Kang, Yo Han Ahn, Inseong Oh, Eun Young Song, Jongwon Ha
Förderung
- Seoul National University Hospital
Zitieren
APA
Han, A., Min, S., Jo, E. A., Lee, H., Kim, Y. C., Han, S. S., Kang, H. G., Ahn, Y. H., Oh, I., Song, E. Y., & Ha, J. (2024). Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.44.1.64
Vancouver
Han A, Min S, Jo EA, Lee H, Kim YC, Han SS, et al. Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients. Annals of Laboratory Medicine. 2024. doi:10.3343/alm.2024.44.1.64
BibTeX
@article{Han2024,
author = {Han, Ahram and Min, Sangil and Jo, Eun-Ah and Lee, Hajeong and Kim, Yong Chul and Han, Seung Seok and Kang, Hee Gyung and Ahn, Yo Han and Oh, Inseong and Song, Eun Young and Ha, Jongwon},
title = {Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients},
journal = {Annals of Laboratory Medicine},
year = {2024},
doi = {10.3343/alm.2024.44.1.64}
}
EUVIMED